Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-27 Sale |
2021-04-29 4:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,884 | $216.06 | $839,193 | 48,383 (Indirect Direct) |
View |
| 2021-04-05 Sale |
2021-04-07 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,686 | $214.14 | $361,046 | 35,834 (Direct) |
View |
| 2021-03-05 Sale |
2021-03-08 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
5,141 | $209.69 | $1,078,018 | 8,253 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
2,782 | $211.45 | $588,255 | 10,053 (Indirect Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
1,080 | $213.47 | $230,552 | 15,053 (Indirect Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,586 | $213.42 | $765,307 | 48,383 (Indirect Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
3,028 | $213.38 | $646,125 | 30,837 (Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
3,634 | $213.54 | $775,989 | 41,243 (Indirect Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,028 | $213.39 | $646,139 | 33,589 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
4,295 | $211.83 | $909,828 | 16,997 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
9,264 | $211.83 | $1,962,366 | 54,915 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
7,825 | $211.83 | $1,657,556 | 36,281 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
7,825 | $211.82 | $1,657,481 | 47,775 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
7,825 | $211.83 | $1,657,590 | 39,033 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
1,498 | $210.57 | $315,437 | 24,032 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,686 | $210.56 | $355,012 | 38,864 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
4,460 | $210.55 | $939,068 | 71,792 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
4,318 | $210.56 | $909,179 | 50,346 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
5,156 | $210.55 | $1,085,593 | 61,840 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
5,283 | $210.54 | $1,112,274 | 53,098 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-05-03 5:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
0 | $0 | 1,394 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 4:03 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,884 | $0 | 48,383 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,884 | $86.52 | 48,383 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-16 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
199 | $220.17 | 13,021 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-16 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
125 | $220.17 | 384 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-05 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,344 | $214.16 | 37,520 (Direct) |
View |
Ownership |
2021-03-08 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
0 | $0 | 35,121 (Direct) |
View |
| 2021-02-26 Tax Withholding |
2021-03-02 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
2,218 | $212.42 | 10,053 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
547 | $217.57 | 35,226 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,036 | $217.57 | 31,432 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
864 | $217.57 | 15,053 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
2,946 | $217.57 | 48,383 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,416 | $217.57 | 30,837 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,898 | $217.57 | 63,643 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
311 | $217.57 | 33,264 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
2,898 | $217.57 | 41,243 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,416 | $217.57 | 33,589 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,000 | $211.75 | 32,468 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
2,740 | $211.75 | 16,997 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
7,613 | $211.75 | 54,915 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
6,240 | $211.75 | 36,281 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
13,970 | $211.75 | 50,116 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,080 | $211.75 | 66,541 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
6,240 | $211.75 | 47,775 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
6,240 | $211.75 | 39,033 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,365 | $214.16 | 35,773 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,230 | $214.16 | 34,468 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
651 | $214.16 | 25,530 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,344 | $214.16 | 40,550 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
2,421 | $214.16 | 76,252 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,563 | $214.16 | 54,664 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
13,954 | $214.16 | 64,086 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,962 | $214.16 | 68,621 (Direct) |
View |